# Prospective Neurobehavioral Outcomes Follow-up in Primary CNS Lymphoma Patients Treated With Cranial Radiotherapy Combined With or Without MTX-based Chemotherapy According to the Multidisciplinary Treatment Guidelines Implemented at a Single Institute

> **NCT02655744** · — · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 25 (estimated)

## Conditions studied

- Primary Central Nervous System Lymphoma

## Interventions

- **RADIATION:** Standard treatment protocol with combined chemoradiation

## Key facts

- **NCT ID:** NCT02655744
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2023-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02655744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02655744, "Prospective Neurobehavioral Outcomes Follow-up in Primary CNS Lymphoma Patients Treated With Cranial Radiotherapy Combined With or Without MTX-based Chemotherapy According to the Multidisciplinary Treatment Guidelines Implemented at a Single Institute". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02655744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
